Delivery Order SPE2DB25D3109-SPE2DB25FPLBD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Veltassa 8.4 GM Powder Packet in a quantity of 30 units, with a ceiling value of $2,716.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $2,565.83 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $7,533.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood....
- The Defense Logistics Agency awarded a $2,052.60 delivery order to AmerisourceBergen Drug Corp for Veltassa 16.8 GM powder packets (30-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used in the treatment of hyperkalemia, a condition commonly requiring...
- The Defense Logistics Agency awarded a $5,636.48 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). The contract, classified as firm fixed price with no set-aside designation, is scheduled for ultimate completion by July 28, 2025. This delivery order is performed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VELTASSA 8.4 GM Powder Packet 30S, a pharmaceutical product, on August 25, 2025. The contract carries a ceiling value of $1,358.10 and utilizes firm fixed price pricing with an ultimate completion date of August 26, 2025. This award represents a non-competitive delivery order, meaning it falls under an existing contract vehicle rather than a standalone competitive procurement. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,921.77 for VELTASSA 8.4 GM powder packets (30-count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order will be fulfilled from...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Veltassa 8.4 GM powder packets. The award has a ceiling value of $4,899.12 and a period of performance through May 9, 2025. The contract is a firm fixed price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM Powder Packet 30S, a pharmaceutical product. The contract has a ceiling value of $1,211.08 and a period of performance through August 27, 2024. It is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, will deliver these medical supplies to support military treatment facilities and federal healthcare programs. This delivery...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FPLBDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Veltassa 8.4 GM Powder Packet (30-count) with a ceiling value of $1,358.10. This is a firm fixed price delivery order with no set-aside designation, meaning the award was made through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other government healthcare systems. The company's comprehensive IDC vehicle enables it to supply a broad range of pharmaceutical products, specialty medications, and medical supplies to support military healthcare programs globally. Veltassa is a potassium-binding medication used in the management of hyperkalemia, and this delivery order represents one of numerous competitively awarded transactions demonstrating the company's capability to fulfill federal medical supply requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/28/25 |